(File photo by Dave Bedard)

Bayer resolves more U.S. Roundup cases

Judge keeps pause on litigation

Reuters — Attorneys for Bayer and U.S. consumers suing the company over allegations its Roundup herbicide caused cancer told a judge on Thursday they are continuing to resolve thousands more U.S. cases, improving prospects for its US$11 billion deal to end the litigation. The hearing was a contrast to the contentious tone among the parties […] Read more

Bayer’s cross symbol hangs in a terminal at Frankfurt International Airport. (Typhoonski/iStock Editorial/Getty Images)

Investors pile into Bayer bond to pay settlement charges

Amsterdam | Reuters — Investors piled into a Bayer bond on Wednesday that will help pay for a long-negotiated settlement of U.S. lawsuits claiming its widely-used herbicide Roundup caused cancer. Demand for the four-tranche bond sale, whose proceeds will include the litigation payments, exceeded 17.5 billion euros, nearly three times the six billion euros (C$9.15 […] Read more



(Dave Bedard photo)

Roundup cancer trial postponed to continue settlement talks

Reuters — Bayer AG said on Friday it has reached an agreement with plaintiffs’ lawyers to postpone a Missouri jury trial over allegations its herbicide Roundup causes cancer, to provide room for negotiations to settle the litigation. “While Bayer is constructively engaged in the mediation process, there is no comprehensive agreement at this time. There […] Read more






(Dave Bedard photo)

Bayer reaps profit lift from Monsanto

Leverkusen, Germany | Reuters –– Bayer’s US$63 billion purchase of seed and chemical firm Monsanto made its mark on the German company’s fourth quarter earnings on Wednesday, lifting profit and boding well for the peak season of its enlarged agriculture business. However, mounting litigation risks related to Monsanto still cast a pall over an adjusted […] Read more